ACYLIERTE GLP-1/GLP-2 DUALE AGONISTE

Patent europeic · EP3551651 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3551651
Numer da la dumonda
EP17832211
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
11-12-2017
Publitgà
16-10-2019
Concedì
06-03-2024
La protecziun finescha il pli tard
10-12-2037
Proxima taxa annuala scadenta
31-12-2026
Classas IPC
C07K 14/605 (2006.01)
A61K 38/26 (2006.01)
Prioritad
DK PA201600757 09.12.2016
Dumonda PCT
PCT/EP2017/082290 11.12.2017
Publicaziun PCT
WO2018/104561 14.06.2018
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-01-2026

    Midada

    Published in Swissreg on 01.01.2026

  2. 15-01-2025

    Midada

    Published in Swissreg on 15.01.2025

  3. 01-01-2025

    Midada

    Published in Swissreg on 01.01.2025

  4. 06-03-2024

    Concedì

    Published in Swissreg on 06.03.2024

Partidas

Possessur

Zealand Pharma A/S

Sydmarken 11, 2860 Søborg, DK

Inventur

DUE LARSEN, Bjarne

DK-4000 Roskilde, DK

GIEHM, Lise

DK-2000 Frederiksberg, DK

EDWARDS, Alistair Vincent Gordon

DK-2300 Copenhagen S, DK

GRIFFIN, Jonathan

SE-22651 Lund, SE

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.